Detalhe da pesquisa
1.
A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
Neurobiol Dis
; 159: 105507, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509608
2.
Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease.
Hum Mol Genet
; 28(19): 3244-3254, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31261387
3.
TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.
Proc Natl Acad Sci U S A
; 114(9): 2389-2394, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193887